Associations between multiple myeloma and other malignancies

被引：4
|
作者：
Landgren, Ola [1 ]
Polliack, Aaron [2 ]
Tadmor, Tamar [3 ]
机构：
[1] NCI, Multiple Myeloma Sect, NIH, Ctr Canc Res,Med Oncol Branch, Bethesda, MD 20892 USA
[2] Hebrew Univ Jerusalem, Sch Med, Hadassah Univ Hosp, Dept Hematol, IL-91010 Jerusalem, Israel
[3] Bnai Zion Med Ctr, Hematol Oncol Unit, Haifa, Israel
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 02期
关键词：
D O I：
10.3109/10428194.2010.538942
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [1] Multiple myeloma and other malignancies
    Patakiouta-Boukali, F.
    Tsiapla, T.
    Galidis, E.
    Triantafillidou, E.
    Chatzileontiadou, S.
    Rapi, K.
    Papaioannou, M.
    Hatjiharissi, E.
    VIRCHOWS ARCHIV, 2018, 473 : S270 - S270
  • [2] Inhibition of VEGF signaling pathways in multiple myeloma and other malignancies
    Podar, Klaus
    Anderson, Kenneth C.
    CELL CYCLE, 2007, 6 (05) : 538 - 542
  • [3] Multiple Myeloma and Other Malignancies: A Pilot Study From the Houston VA
    Munker, Reinhold
    Shi, Runhua
    Lin, Derek
    Guo, Shan
    Hayes, Teresa G.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (02): : 102 - 106
  • [4] Multiple Myeloma and Second Malignancies
    Engelhardt, Monika
    Waesch, Ralph
    Landgren, Ola
    Kleber, Martina
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (02): : 98 - 101
  • [5] EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
    Rosemarie Tremblay-LeMay
    Nasrin Rastgoo
    Maryam Pourabdollah
    Hong Chang
    Biomarker Research, 6
  • [6] EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
    Tremblay-LeMay, Rosemarie
    Rastgoo, Nasrin
    Pourabdollah, Maryam
    Chang, Hong
    BIOMARKER RESEARCH, 2018, 6
  • [7] Inhibition of USP7 for the treatment of multiple myeloma and other malignancies.
    Nicholson, Benjamin
    Kodrasov, Matthew P.
    LaRocque, James P.
    Eddins, Michael J.
    Kumar, Suresh
    Chauhan, Dharminder
    Anderson, Kenneth C.
    Mattern, Michael R.
    CLINICAL CANCER RESEARCH, 2015, 21
  • [8] The role of VWF/FVIII in thrombosis and cancer progression in multiple myeloma and other hematological malignancies
    Comerford, Claire
    Glavey, Siobhan
    Quinn, John
    O'Sullivan, Jamie M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (08) : 1766 - 1777
  • [9] HEALTHCARE RESOURCE UTILIZATION IN JAPANESE PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA OR WITH OTHER MALIGNANCIES
    Akiyama, S.
    Nishio, M.
    VALUE IN HEALTH, 2020, 23 : S482 - S482
  • [10] Review of the patient-centered communication landscape in multiple myeloma and other hematologic malignancies
    LeBlanc, Thomas W.
    Baile, Walter E.
    Eggly, Susan
    Bylund, Carma L.
    Kurtin, Sandra
    Khurana, Monica
    Najdi, Rani
    Blaedel, Julie
    Wolf, Jeffrey L.
    Fonseca, Rafael
    PATIENT EDUCATION AND COUNSELING, 2019, 102 (09) : 1602 - 1612
12345